| Unknown | NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy" Non Small Cell Lung Cancer | N/A | 2018-01-05 |
| Unknown | Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSC Non Small Cell Lung Cancer | Phase 2 | 2016-08-02 |
| Unknown | Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment Metastatic Colorectal Cancer | Phase 2 | 2016-01-01 |
| Completed | Cabazitaxel in Relapsed and Metastatic NSCLC NSCLC | Phase 2 | 2012-09-01 |
| Completed | Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer Stomach and Gastro-Esophageal Junction (GEJ) Cancer | Phase 2 | 2012-09-01 |
| Completed | Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer Ovarian Cancer | — | 2012-03-01 |
| Completed | Pazopanib in Relapsed and Refractory Small Cell Lung Cancer SCLC | Phase 2 | 2011-11-01 |
| Terminated | Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer Breast Cancer | Phase 2 | 2011-10-01 |
| Completed | Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer Metastatic Breast Cancer | — | 2011-07-01 |
| Terminated | Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer Gastric Cancer | Phase 1 / Phase 2 | 2011-07-01 |
| Completed | Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer Breast Cancer | — | 2011-04-01 |
| Completed | Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC NSCLC | Phase 1 / Phase 2 | 2011-02-01 |
| Unknown | Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer CRC | Phase 3 | 2010-10-01 |
| Terminated | Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC NSCLC | Phase 2 | 2010-03-01 |
| Completed | Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment Non Small Cell Lung Cancer | — | 2010-02-01 |
| Terminated | Myocet Plus Endoxan for Older Patients With Breast Cancer Breast Cancer | Phase 2 | 2009-09-01 |
| Terminated | Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer Breast Cancer | Phase 2 | 2009-09-01 |
| Completed | Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colo Metastatic Colorectal Cancer | — | 2009-07-01 |
| Completed | Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer Non Small Cell Lung Cancer | Phase 2 | 2008-11-01 |
| Completed | Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer Non Small Cell Lung Cancer | Phase 2 | 2008-11-01 |
| Terminated | Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC Colorectal Cancer | Phase 2 | 2008-11-01 |
| Terminated | Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer Non-small-cell Lung Cancer | Phase 2 | 2008-07-01 |
| Completed | Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer Metastatic Breast Cancer | Phase 1 | 2008-06-01 |
| Completed | Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer Non-small-cell Lung Cancer | Phase 2 | 2008-06-01 |
| Completed | Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2008-05-01 |
| Terminated | Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer Breast Cancer | Phase 2 | 2008-04-01 |
| Completed | Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2008-04-01 |
| Terminated | Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer Colorectal Cancer | Phase 2 | 2008-04-01 |
| Completed | Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer Gastric Cancer | Phase 2 | 2008-04-01 |
| Completed | Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer Non-small-cell Lung Cancer | Phase 2 | 2008-04-01 |
| Terminated | Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) Bladder Cancer | Phase 2 | 2008-02-01 |
| Terminated | Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung C Non-Small-Cell Lung Cancer | Phase 2 | 2008-02-01 |
| Completed | Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel Non Small Cell Lung Cancer | Phase 2 | 2008-01-01 |
| Completed | Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas Ovarian Cancer | Phase 1 / Phase 2 | 2008-01-01 |
| Completed | Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Pos Breast Cancer | Phase 3 | 2007-10-01 |
| Terminated | Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2006-12-01 |
| Terminated | Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC Non-small-cell Lung Cancer | Phase 3 | 2006-12-01 |
| Completed | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC Colorectal Cancer | Phase 3 | 2006-12-01 |
| Completed | Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV Non Small Cell Lung Cancer | Phase 2 | 2006-11-01 |
| Completed | Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV Non Small Cell Lung Cancer | Phase 2 | 2006-10-01 |
| Completed | Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma Ovarian Cancer | Phase 1 / Phase 2 | 2006-06-01 |
| Completed | Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) Non Small Cell Lung Cancer | Phase 1 / Phase 2 | 2006-05-01 |
| Completed | Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC) Non Small Cell Lung Cancer | Phase 3 | 2006-04-01 |
| Terminated | Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemot Non Small Cell Lung Cancer | Phase 2 | 2006-03-01 |
| Completed | Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Col Metastatic Colorectal Cancer | Phase 2 | 2006-03-01 |
| Terminated | Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma Ovarian Cancer | Phase 2 | 2005-10-01 |
| Completed | Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer Breast Cancer | Phase 3 | 2004-10-01 |
| Completed | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxe Breast Cancer | Phase 3 | 2004-08-01 |
| Completed | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Pa Gastric Cancer | Phase 2 | 2004-07-01 |
| Completed | Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carci Non-Small Cell Lung Cancer | Phase 3 | 2004-07-01 |
| Completed | Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Non Small Cell Lung Cancer | Phase 3 | 2004-04-01 |
| Terminated | Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breas Breast Cancer | Phase 2 | 2003-12-01 |
| Terminated | Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer Breast Cancer | Phase 2 | 2003-06-01 |
| Terminated | Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients Breast Cancer | Phase 3 | 2003-04-01 |
| Completed | Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cance Non Small Cell Lung Cancer | Phase 3 | 2003-01-01 |
| Completed | Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic B Breast Cancer | Phase 3 | 2002-05-01 |
| Completed | Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer Breast Cancer | Phase 3 | 2002-04-01 |
| Completed | Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) Hig Breast Cancer | Phase 3 | 2001-06-01 |